Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 20, 2022
0Patent Application Number
157005380
Date Filed
September 11, 2017
0Patent Citations
Patent Primary Examiner
The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
